We are live on ! Find out more
AGM

Alpine Global Management Portfolio holdings

AUM $668M
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-1.78%
1 Year Est. Return
+20.22%
3 Year Est. Return
+100.14%
5 Year Est. Return
+103.13%
10 Year Est. Return
+677.44%
AUM
$575M
AUM Growth
+$58.8M
Cap. Flow
+$74.4M
Cap. Flow %
12.93%
Top 10 Hldgs %
36.71%
Holding
556
New
356
Increased
46
Reduced
31
Closed
94

Sector Composition

Rank Sector Weight
1 Healthcare 17.49%
2 Technology 14.77%
3 Financials 8.87%
4 Industrials 5.4%
5 Communication Services 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUMA icon
351
Humacyte
HUMA
$169M
$128K 0.02%
+26,744
New +$139K
NAGE
352
Niagen Bioscience
NAGE
$251M
$127K 0.02%
+46,363
New +$155K
INDI icon
353
indie Semiconductor
INDI
$647M
$126K 0.02%
+20,501
New +$130K
AGNT
354
AGNT Inc
AGNT
$620M
$126K 0.02%
+11,187
New +$122K
GRNT icon
355
Granite Ridge Resources
GRNT
$621M
$125K 0.02%
+19,680
New +$127K
SLDB icon
356
Solid Biosciences
SLDB
$799M
$124K 0.02%
+21,918
New +$196K
BCRX icon
357
BioCryst Pharmaceuticals
BCRX
$2.44B
$124K 0.02%
+20,071
New +$111K
GOEV
358
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$123K 0.02%
+2,898
New +$142K
KYTX icon
359
Kyverna Therapeutics
KYTX
$432M
$121K 0.02%
+16,169
New +$247K
RSI icon
360
Rush Street Interactive
RSI
$3.18B
$121K 0.02%
+12,612
New +$101K
PESI icon
361
Perma-Fix Environmental Services
PESI
$345M
$121K 0.02%
+11,909
New +$132K
FBLG icon
362
FibroBiologics
FBLG
$4.04M
$120K 0.02%
+1,205
New +$230K
EYPT icon
363
EyePoint Inc
EYPT
$981M
$117K 0.02%
+13,471
New +$188K
CADL icon
364
Candel Therapeutics
CADL
$689M
$116K 0.02%
+18,761
New +$141K
CAPR icon
365
Capricor Therapeutics
CAPR
$380M
$115K 0.02%
+24,168
New +$135K
CATO icon
366
Cato Corp
CATO
$67.1M
$115K 0.02%
+20,800
New +$112K
IOVA icon
367
Iovance Biotherapeutics
IOVA
$2.07B
$113K 0.02%
+14,106
New +$151K
FOLD
368
DELISTED
Amicus Therapeutics
FOLD
$112K 0.02%
+11,297
New +$116K
DIBS icon
369
1stdibs.com
DIBS
$150M
$111K 0.02%
+24,761
New +$135K
MRAM icon
370
Everspin Technologies
MRAM
$309M
$111K 0.02%
+18,536
New +$123K
GEOS icon
371
Geospace Technologies
GEOS
$84.2M
$111K 0.02%
+12,323
New +$139K
BLNK icon
372
Blink Charging
BLNK
$67.7M
$111K 0.02%
+40,356
New +$115K
PRCH icon
373
Porch Group
PRCH
$1.38B
$110K 0.02%
73,097
+63,097
+631% +$176K
NUVB icon
374
Nuvation Bio
NUVB
$2.28B
$110K 0.02%
+37,566
New +$115K
TERN
375
DELISTED
Terns Pharmaceuticals
TERN
$109K 0.02%
+16,078
New +$97.4K

Similar funds

Alpine Global Management's Q2 2024 Portfolio in Review

As of Q2 2024, Alpine Global Management held 556 positions worth $575M, up 11% from $516M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Alpine Global Management deployed $74.4M of net new capital in Q2 2024, opening 356 new positions and adding to 46 existing holdings. Its largest new stake was Strategy Inc: 192,280 shares worth $26.5M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Robinhood, an estimated $19.6M trimmed.

  • Alpine Global Management's largest Q2 2024 buy was Strategy Inc: 192,280 shares worth $26.5M.
  • Alpine Global Management added most to Archer Aviation in Q2 2024, an estimated $6.74M increase.
  • Alpine Global Management's biggest Q2 2024 reduction was Robinhood, cutting an estimated $19.6M.
  • Alpine Global Management fully exited Agiliti Inc in Q2 2024, selling an estimated $26.4M.
  • Alpine Global Management's ten largest holdings make up 37% of its $575M portfolio in Q2 2024.
  • Alpine Global Management opened 356 new positions and closed 94 in Q2 2024.
  • Alpine Global Management's portfolio value rose 11% quarter-over-quarter to $575M.

Based on Alpine Global Management's 13F filing for Q2 2024, filed 14 Aug 2024.